New blood test may predict heart damage in kids treated for cancer
NCT ID NCT07253077
First seen Jan 09, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study aims to find early warning signs in the blood that could predict heart damage in children and teens who have been treated with a type of chemotherapy called anthracyclines. Researchers will measure specific proteins and other substances in the blood of 40 childhood cancer survivors and compare them to healthy children. The goal is to see if these markers can help doctors identify heart problems before they become serious.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPEUTIC TOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.